Literature DB >> 6946555

Pharmacokinetic factors influencing variability in human drug response.

B Marchant.   

Abstract

It is well recognised that the clinical response to drug administration varies widely between individuals and that most of this variability is pharmacokinetic in origin. In general, variability arises because of inter-individual differences in rates of drug absorption, drug distribution and elimination, either by metabolism or excretion. Variability of drug response is also a consequence of a variety of drug interactions which may influence pharmacokinetic parameters. Among the many factors which are responsible for the variation in human drug response, age is relatively important. As a consequence of impaired metabolism and excretion the inter-individual variation in the kinetic of many drugs is much greater in the elderly. Also the degree of plasma-protein binding, in turn, influences the distribution, action, metabolism and renal excretion of drugs. Thus changes in plasma protein binding of drugs, e.g. in diseased states, may give rise to altered pharmacokinetic and possibly altered drug response. The above factors influencing variability in drug response are discussed with particular reference to examples of non-steroidal antiinflammatory drugs used in the treatment of rheumatic diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6946555     DOI: 10.3109/03009748109095328

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  4 in total

1.  Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.

Authors:  Linda C Johansson; Lars Frison; Ulrika Logren; Gunnar Fager; David Gustafsson; Ulf G Eriksson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.

Authors:  Shabbir Ahmed; Zhan Zhou; Jie Zhou; Shu-Qing Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-10-08       Impact factor: 7.691

3.  Closed-loop wearable naloxone injector system.

Authors:  Justin Chan; Vikram Iyer; Anran Wang; Alexander Lyness; Preetma Kooner; Jacob Sunshine; Shyamnath Gollakota
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

4.  Evaluation of sex differences in the pharmacokinetics of oral sumatriptan in healthy Korean subjects using population pharmacokinetic modeling.

Authors:  Boram Ohk; Sookjin Seong; Joomi Lee; Miri Gwon; Wooyoul Kang; Haewon Lee; Youngran Yoon; Heedoo Yoo
Journal:  Biopharm Drug Dispos       Date:  2022-01-19       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.